Last update 10 Jan 2025

Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesMouth and Tooth Diseases
Active Indication
MumpsParotitis
Inactive Indication-
Originator Organization
Shanghai Qingsai Biotechnology Co., Ltd.Shanghai Qingsai Biotechnology Co., Ltd.
Active Organization
Shanghai Qingsai Biotechnology Co., Ltd.Shanghai Qingsai Biotechnology Co., Ltd.Beijing Cell-fusion Biotechnology Co. Ltd.Beijing Cell-fusion Biotechnology Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)
CTR20234050
/ Active, not recruitingPhase 2
单中心、随机、双盲、同类制品平行对照评价基因重组腮腺炎减毒活疫苗（F 基因 型）在中国6-59周岁健康受试者中的安全性和免疫原性的Ⅱ期临床试验
[Translation] A single-center, randomized, double-blind, similar product parallel control phase II clinical trial to evaluate the safety and immunogenicity of the recombinant mumps live attenuated vaccine (F genotype) in healthy subjects aged 6-59 years in China
CTR20230925
/ Active, not recruitingPhase 1
基因重组腮腺炎减毒活疫苗（F基因型）Ⅰ期临床试验
[Translation] Phase I clinical trial of recombinant live attenuated mumps vaccine (F genotype)
100 Clinical Results associated with Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)
Login to view more data
100 Translational Medicine associated with Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)
Login to view more data
100 Patents (Medical) associated with Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)
Login to view more data
100 Deals associated with Mumps Vaccine, Live, Recombinant(F genotype)(Shanghai King-cell)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MumpsPhase 2
CN
Beijing Cell-fusion Biotechnology Co. Ltd.Beijing Cell-fusion Biotechnology Co. Ltd.
23 Dec 2023
ParotitisIND Approval
CN
Shanghai Qingsai Biotechnology Co., Ltd.Shanghai Qingsai Biotechnology Co., Ltd.
23 May 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free